1
English
Welcome
Thank you for choosing the VPAP Adapt or H5i.
Before operating these devices, please read the entire Clinical and Information Guides.
CAUTION
In the US, Federal law restricts this device to sale by or on the order of a physician.
VPAP Adapt indications for use
The S9 VPAP Adapt is indicated for the treatment of patients weighing more than 66 lb (30 kg) with
obstructive sleep apnea (OSA), central and/or mixed apneas, or periodic breathing. The S9 VPAP Adapt is
intended for home and hospital use.
VPAP Adapt contraindications
ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with
reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep
apnea.
Positive airway pressure therapy may be contraindicated in some patients with the following pre-existing
conditions:
• severe bullous lung disease
• pneumothorax or pneumomediastinum
• pathologically low blood pressure, particularly if associated with intravascular volume depletion
• dehydration
• cerebrospinal fluid leak, recent cranial surgery, or trauma.
VPAP Adapt adverse effects
Patients should report unusual chest pain, severe headache, or increased breathlessness to their
prescribing physician. An acute upper respiratory tract infection may require temporary discontinuation of
treatment.
The following side effects may arise during the course of therapy with these devices:
• drying of the nose, mouth, or throat
• nosebleed
• bloating
• ear or sinus discomfort
• eye irritation
• skin rashes.
H5i indications for use
The H5i is indicated for the humidification of the air delivered from a CPAP or bilevel device. The H5i is
for use only as recommended by a physician. The H5i is intended for single patient re-use in the home
environment and re-use in a hospital/institutional environment.
H5i contraindications
The H5i is contraindicated for use with patients whose upper (supraglottic) airway has been bypassed.
3681064r1 Book.indb 1 23/10/2015 4:32:23 PM